Compare
PRLD · 1 ticker
Price
100 is the close on the leftSnapshot
best blue · worst red
PRLD
Prelude Therapeutics Inc
3.48
-0.04 (-1.14%)
Valuation
| Index | RUT |
|---|---|
| Market Cap | $277.69M |
| Enterprise Value | 143.58M |
| Income | -60.49M |
| Sales | 22.42M |
| Book / share | 1.68 |
| Cash / share | 1.90 |
| Dividend Gr. 3/5Y | - - |
| Employees | 79 |
| IPO | Sep 25, 2020 |
Ratios
| Price / sales | 12.39 |
|---|---|
| Price / book | 2.08 |
| Price / cash | 1.83 |
| Value / sales | 6.40 |
| Quick Ratio | 4.07 |
| Current Ratio | 4.07 |
| Debt / equity | 0.13 |
| Long-term debt / equity | 0.11 |
| Options and short | Yes / Yes |
Earnings
| Earnings / share | -0.79 |
|---|---|
| Earnings next year | -0.48 |
| Earnings next quarter | 0.01 |
| Earnings this year | 68.84% |
| Earnings growth, 5 years | 57.36% |
| Past earnings growth | 19.05% 0.15% |
| Past sales growth | - - |
| Earnings vs last year | 55.73% |
| Sales vs last year | 220.34% |
| Earnings vs last quarter | 65.57% |
| Earnings | Aug 11 BMO · 94 days ago |
| Surprise | 28.83% - |
Ownership
| Insiders own | 43.95% |
|---|---|
| Insider trades | 0.00% |
| Institutions own | 45.80% |
| Institution trades | 18.04% |
| Return on assets | -39.76% |
| Return on equity | -57.73% |
| Return on capital | -40.70% |
| Gross Margin | 92.92% |
| Operating margin | -300.56% |
| Profit Margin | -269.75% |
| 20-day average | -6.78% |
| 50-day average | -13.02% |
| 200-day average | -15.09% |
Technical
| Shares out | 65.03M |
|---|---|
| Shares floating | 44.73M |
| Short / float | 9.34% |
| Short ratio | 8.69 |
| Short interest | 4.18M |
| 52-week high | 6.83 -49.0% |
| 52-week low | 1.30 +168.7% |
| Volatility | 9.26% 8.81% |
| Average range | 0.31 |
| Strength index | 41.02 |
| Market sensitivity | 1.20 |
| Relative volume | 0.00 |
| Avg Volume | 480.74K |
| Volume | 6 |
Performance
| Perf Week | -3.34% |
|---|---|
| Perf Month | 4.81% |
| Perf Quarter | -38.19% |
| Perf Half Y | -22.33% |
| Perf YTD | 19.99% |
| Perf Year | 130.44% |
| Perf 3Y | 15.60% |
| Perf 5Y | -78.52% |
| Recommendation | 1.00 |
| Target Price | 9.20 |
| Prev Close | 3.52 |
| Price | 3.48 |
| Change % | -1.14% |
Compare
| PRLD | |
|---|---|
| Price | 3.48 |
| Change | -0.04 (-1.14%) |
Compare · Valuation
| PRLD | |
|---|---|
| Index | RUT |
| Market Cap | $277.69M |
| Enterprise Value | 143.58M |
| Income | -60.49M |
| Sales | 22.42M |
| Book / share | 1.68 |
| Cash / share | 1.90 |
| Dividend Gr. 3/5Y | - - |
| Employees | 79 |
| IPO | Sep 25, 2020 |
Compare · Ratios
| PRLD | |
|---|---|
| Price / sales | 12.39 |
| Price / book | 2.08 |
| Price / cash | 1.83 |
| Value / sales | 6.40 |
| Quick Ratio | 4.07 |
| Current Ratio | 4.07 |
| Debt / equity | 0.13 |
| Long-term debt / equity | 0.11 |
| Options and short | Yes / Yes |
Compare · Earnings
| PRLD | |
|---|---|
| Earnings / share | -0.79 |
| Earnings next year | -0.48 |
| Earnings next quarter | 0.01 |
| Earnings this year | 68.84% |
| Earnings growth, 5 years | 57.36% |
| Past earnings growth | 19.05% 0.15% |
| Past sales growth | - - |
| Earnings vs last year | 55.73% |
| Sales vs last year | 220.34% |
| Earnings vs last quarter | 65.57% |
| Earnings | Aug 11 BMO · 94 days ago |
| Surprise | 28.83% - |
Compare · Ownership
| PRLD | |
|---|---|
| Insiders own | 43.95% |
| Insider trades | 0.00% |
| Institutions own | 45.80% |
| Institution trades | 18.04% |
| Return on assets | -39.76% |
| Return on equity | -57.73% |
| Return on capital | -40.70% |
| Gross Margin | 92.92% |
| Operating margin | -300.56% |
| Profit Margin | -269.75% |
| 20-day average | -6.78% |
| 50-day average | -13.02% |
| 200-day average | -15.09% |
Compare · Technical
| PRLD | |
|---|---|
| Shares out | 65.03M |
| Shares floating | 44.73M |
| Short / float | 9.34% |
| Short ratio | 8.69 |
| Short interest | 4.18M |
| 52-week high | 6.83 -49.0% |
| 52-week low | 1.30 +168.7% |
| Volatility | 9.26% 8.81% |
| Average range | 0.31 |
| Strength index | 41.02 |
| Market sensitivity | 1.20 |
| Relative volume | 0.00 |
| Avg Volume | 480.74K |
| Volume | 6 |
Compare · Performance
| PRLD | |
|---|---|
| Perf Week | -3.34% |
| Perf Month | 4.81% |
| Perf Quarter | -38.19% |
| Perf Half Y | -22.33% |
| Perf YTD | 19.99% |
| Perf Year | 130.44% |
| Perf 3Y | 15.60% |
| Perf 5Y | -78.52% |
| Recommendation | 1.00 |
| Target Price | 9.20 |
| Prev Close | 3.52 |
| Price | 3.48 |
| Change % | -1.14% |